Prevalence and Clinical Impact of Airway Opening Pressure in Post-Cardiac Surgery Patients

September 16, 2025 updated by: François Lellouche, Laval University

Prevalence and Clinical Impact of Airway Opening Pressure in Post-Cardiac Surgery Patients: A Prospective Observational Study

Airway opening pressure is a key parameter in assessing respiratory mechanics. Current practice primarily relies on indirect assessments of lung mechanics, but growing evidence suggests that direct airway opening pressure measurement could enhance individualized ventilatory strategies. Significant airway opening pressure suggests incomplete alveolar recruitment at end-expiration, which may contribute to ventilation-perfusion mismatch, increased respiratory effort, and postoperative pulmonary complications such as atelectasis and impaired gas exchange. Determining the prevalence and clinical relevance of significant airway opening pressure in post-cardiac surgery patients could contribute to more personalized respiratory strategies and improve postoperative care.

Study Overview

Status

Active, not recruiting

Study Type

Interventional

Enrollment (Estimated)

196

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Quebec
      • Québec, Quebec, Canada
        • Institut universitaire de cardiologie et de pneumologie de Québec - Université Laval

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Adult (≥18 years)
  • Undergoing elective coronary artery bypass grafting (CABG) or valve surgery, or combined procedures with expected postoperative mechanical ventilation

Exclusion Criteria:

- Patient receiving invasive mechanical ventilation prior to surgery

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Post operative cardiac surgery
Airway opening pressure will be measured within one hour of intensive care unit admission (using a standardized low-flow insufflation maneuver flow 5-6 LPM). The inflection point on the pressure-time or pressure-volume waveform- depending on ventilator model-will define the airway opening pressure.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Prevalence of significant airway opening pressure
Time Frame: up to 1 hour after intensive care admission
airway opening pressure ≥ 5 cmH₂O
up to 1 hour after intensive care admission

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Airway opening pressure prevalence based on body mass index
Time Frame: up to 1 hour
Airway opening pressure prevalence base on Obesity status (body mass index ≥30 vs. <30 kg/m²)
up to 1 hour
Airway opening pressure prevalence based on cardiopulmonary bypass duration
Time Frame: up to 1 hour
Airway opening pressure prevalence based on cardiopulmonary bypass duration (minutes)
up to 1 hour
Airway opening pressure prevalence based on left ventricular dysfunction
Time Frame: up to 1 hour
Airway opening pressure prevalence based on left ventricular dysfunction (Ieft ventricular ejection fraction < 50 percent vs > 50 percent)
up to 1 hour
Airway opening pressure prevalence based on inotropic support
Time Frame: up to 1 hour
Airway opening pressure prevalence based on use of amines (< 0.1 mcg/kg/min or norepinephrine equivalent vs > 0.1 mcg/kg/min or norepinephrine equivalent)
up to 1 hour
Airway opening pressure prevalence based on age
Time Frame: up to 1 hour
Airway opening pressure prevalence base on age
up to 1 hour
Airway opening pressure prevalence based on intraoperative fluid balance
Time Frame: up to 1 hour
Airway opening pressure prevalence base on intraoperative fluid balance
up to 1 hour
Feasibility of airway opening pressure measurement
Time Frame: up to 1 hour
proportion of patients in whom the maneuver is successfully completed
up to 1 hour
Positive end expiratory pressure level
Time Frame: up to 1 hour
Number of times Positive end expiratory pressure is set greater than measured airway opening pressure
up to 1 hour
Extubation
Time Frame: Day7
Correlation between airway opening pressure and time to extubation
Day7
Patient position
Time Frame: up to 1 hour
Comparison of airway opening pressure values in flat versus semi-recumbent (30-degree) positions
up to 1 hour
Hemodynamic tolerance base on blood pressure drop
Time Frame: up to 15 minutes
Evaluation of hemodynamic tolerance based on arterial pressure during positive end-expiratory pressure adjustment (if inotropic agents are required, an increase of more than 0.05 mcg/kg/min in norepinephrine equivalent is considered significant)
up to 15 minutes
Hemodynamic tolerance base on pulse oxygen saturation drop
Time Frame: up to 15 minutes
Evaluation of hemodynamic tolerance based on pulse oxygen saturation. A decrease in pulse oxygen saturation of 5 percent from baseline or more is considered significant.
up to 15 minutes
Non-interruptive airway opening pressure measurement method
Time Frame: up to 1 hour
The novel non-interruptive airway opening pressure measurement method will be validated
up to 1 hour

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 27, 2025

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

June 1, 2027

Study Registration Dates

First Submitted

August 27, 2025

First Submitted That Met QC Criteria

September 16, 2025

First Posted (Estimated)

September 23, 2025

Study Record Updates

Last Update Posted (Estimated)

September 23, 2025

Last Update Submitted That Met QC Criteria

September 16, 2025

Last Verified

September 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 2026-4399

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiac Surgery

Clinical Trials on Airway opening pressure

Subscribe